“It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty,” a spokesman added, saying it would depend on animal trials as to whether it could be considered “a promising candidate research vaccine” for Bundibugyo.
Trending
- What to Eat for Better Sleep — and What the Evidence Shows
- Israeli Commander Says Hezbollah Built Border Tunnels and Weapons Caches in Southern Lebanon
- Most People Don’t Choose Early Retirement — Life Forces It on Them
- How to Handle a Mortgage Rate Spike That Raises Your Monthly Payments
- Sonny Rollins Dies at 95, Leaving Behind the Sound of Modern Jazz
- Why Jarrod Bowen Is Emerging as Liverpool’s Most Logical Salah Replacement
- How Anti-Tech Extremism Became a New Security Concern in the AI Era
- Baby Death in Milwaukee Case Raises Questions Over Fentanyl Exposure and Neglect Charges

